Cargando…
Metabolomic Profiling of Cellular Responses to Carvedilol Enantiomers in Vascular Smooth Muscle Cells
Carvedilol is a non-selective β-blocker indicated in the treatment of hypertension and heart failure. Although the differential pharmacological effects of individual Carvedilol enantiomer is supported by preceding studies, the cellular response to each enantiomer is not well understood. Here we repo...
Autores principales: | Wang, Mingxuan, Bai, Jing, Chen, Wei Ning, Ching, Chi Bun |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991354/ https://www.ncbi.nlm.nih.gov/pubmed/21124793 http://dx.doi.org/10.1371/journal.pone.0015441 |
Ejemplares similares
-
Metabolic profiling of HepG2 cells incubated with S(−) and R(+) enantiomers of anti-coagulating drug warfarin
por: Bai, Jing, et al.
Publicado: (2010) -
Transfersome Encapsulated with the R-carvedilol Enantiomer for Skin Cancer Chemoprevention
por: Shamim, Md Abdullah, et al.
Publicado: (2023) -
Modulation of calcium channels in arterial smooth muscle cells by dihydropyridine enantiomers
Publicado: (1993) -
Temperature and eluent composition effects on enantiomer separation of carvedilol by high-performance liquid chromatography on immobilized amylose-based chiral stationary phases
por: Panella, Cristina, et al.
Publicado: (2019) -
UHPLC Enantiomer Resolution for the ɑ/β-Adrenoceptor Antagonist R/S-Carvedilol and Its Major Active Metabolites on Chiralpak IB N-5
por: Samir, Liza, et al.
Publicado: (2022)